{"hands_on_practices": [{"introduction": "A cornerstone of maternal renal adaptation is the dramatic increase in glomerular filtration rate (GFR), or physiologic hyperfiltration. While routinely estimated using creatinine clearance, this measurement is known to overestimate true GFR due to tubular secretion. This exercise [@problem_id:4470795] provides a hands-on opportunity to dissect these components, using a differential measurement technique to derive a more physiologically accurate GFR and sharpening your understanding of renal clearance principles.", "problem": "A gravida $1$, para $0$ patient at $22$ weeks of gestation is undergoing assessment of renal function in the context of the known pregnancy-associated increase in glomerular filtration rate (GFR). The laboratory provides simultaneous measurements of plasma creatinine and timed urine creatinine collections before and after pharmacologic blockade of tubular secretion. The following data are obtained under steady-state conditions:\n\n- Baseline $30$-minute urine collection: urine volume $36 \\ \\mathrm{mL}$, urinary creatinine concentration $72 \\ \\mathrm{mg/dL}$, plasma creatinine concentration $0.48 \\ \\mathrm{mg/dL}$.\n- Post-cimetidine $20$-minute urine collection (after intravenous cimetidine achieving a level known to block a constant fraction of proximal tubular secretion): urine volume $23 \\ \\mathrm{mL}$, urinary creatinine concentration $68.5 \\ \\mathrm{mg/dL}$, plasma creatinine concentration $0.48 \\ \\mathrm{mg/dL}$.\n- The fraction of tubular creatinine secretion blocked by cimetidine under these dosing conditions is $f = 0.80$.\n- Independently measured body surface area (BSA) is $1.84 \\ \\mathrm{m^2}$.\n\nUsing the mass conservation definition of renal clearance, the physiologic relation between excretion, filtration, and secretion for creatinine, and the effect of a fractional blockade of tubular secretion, derive and compute the best physiologically grounded estimate of the patient’s glomerular filtration rate normalized to $1.73 \\ \\mathrm{m^2}$. Round your answer to four significant figures. Express the final result in $\\mathrm{mL/min}$ per $1.73 \\ \\mathrm{m^2}$.\n\nFor clarity, define all quantities you use, including the distinction between measured creatinine clearance and true glomerular filtration rate (GFR). Also, briefly state why estimated glomerular filtration rate (eGFR) equations based solely on plasma creatinine concentration are limited in pregnancy. Do not use any shortcut formulas beyond fundamental definitions and well-tested physiologic relations.", "solution": "The problem is valid as it is scientifically grounded in established principles of renal physiology, well-posed with sufficient and consistent data, and objectively stated. It requires the application of fundamental definitions to derive a solution, which is a standard approach in quantitative science.\n\nThe solution requires determining the true glomerular filtration rate ($GFR$) by accounting for the tubular secretion of creatinine. The total urinary excretion rate of a substance is the sum of what is filtered by the glomerulus and what is secreted by the tubules, minus any reabsorption. For creatinine, reabsorption is negligible.\n\nLet's define the key physiological quantities:\n- $GFR$: Glomerular Filtration Rate, the volume of plasma filtered per unit time ($\\mathrm{mL/min}$).\n- $C_{Cr}$: Creatinine Clearance, the measured volume of plasma cleared of creatinine per unit time ($\\mathrm{mL/min}$).\n- $E_{Cr}$: The mass excretion rate of creatinine in urine ($\\mathrm{mg/min}$).\n- $TS_{Cr}$: The net rate of tubular secretion of creatinine into the urine ($\\mathrm{mg/min}$).\n- $P_{Cr}$: The plasma concentration of creatinine ($\\mathrm{mg/mL}$).\n- $U_{Cr}$: The urinary concentration of creatinine ($\\mathrm{mg/mL}$).\n- $\\dot{V}$: The urine flow rate ($\\mathrm{mL/min}$).\n\nThe fundamental relationship for creatinine handling by the kidney is:\n$$\n\\text{Excretion Rate} = \\text{Filtration Rate} + \\text{Secretion Rate}\n$$\nIn mathematical terms:\n$$\nE_{Cr} = (GFR \\times P_{Cr}) + TS_{Cr}\n$$\nThe excretion rate is measured from the urine collection data:\n$$\nE_{Cr} = U_{Cr} \\times \\dot{V}\n$$\nThe standard measured creatinine clearance ($C_{Cr}$) is defined as:\n$$\nC_{Cr} = \\frac{U_{Cr} \\times \\dot{V}}{P_{Cr}} = \\frac{E_{Cr}}{P_{Cr}}\n$$\nSubstituting the first equation into this definition reveals why $C_{Cr}$ overestimates the true $GFR$:\n$$\nC_{Cr} = GFR + \\frac{TS_{Cr}}{P_{Cr}}\n$$\nThe problem provides two sets of measurements, allowing us to solve for the two unknowns, $GFR$ and the baseline tubular secretion rate, which we will denote as $TS_{Cr,1}$. Let the subscript $1$ refer to the baseline condition and $2$ refer to the post-cimetidine condition. The plasma creatinine concentration $P_{Cr}$ is constant at $0.48 \\ \\mathrm{mg/dL}$ or $0.0048 \\ \\mathrm{mg/mL}$.\n\nFirst, we calculate the urinary excretion rates for both conditions.\n\nCondition 1 (Baseline):\n- Time $T_1 = 30 \\ \\mathrm{min}$\n- Urine volume $V_1 = 36 \\ \\mathrm{mL}$\n- Urine creatinine $U_{Cr,1} = 72 \\ \\mathrm{mg/dL} = 0.72 \\ \\mathrm{mg/mL}$\n- Urine flow rate $\\dot{V}_1 = \\frac{V_1}{T_1} = \\frac{36 \\ \\mathrm{mL}}{30 \\ \\mathrm{min}} = 1.2 \\ \\mathrm{mL/min}$\n- Excretion rate $E_{Cr,1} = U_{Cr,1} \\times \\dot{V}_1 = (0.72 \\ \\mathrm{mg/mL}) \\times (1.2 \\ \\mathrm{mL/min}) = 0.864 \\ \\mathrm{mg/min}$\n\nCondition 2 (Post-cimetidine):\n- Time $T_2 = 20 \\ \\mathrm{min}$\n- Urine volume $V_2 = 23 \\ \\mathrm{mL}$\n- Urine creatinine $U_{Cr,2} = 68.5 \\ \\mathrm{mg/dL} = 0.685 \\ \\mathrm{mg/mL}$\n- Urine flow rate $\\dot{V}_2 = \\frac{V_2}{T_2} = \\frac{23 \\ \\mathrm{mL}}{20 \\ \\mathrm{min}} = 1.15 \\ \\mathrm{mL/min}$\n- Excretion rate $E_{Cr,2} = U_{Cr,2} \\times \\dot{V}_2 = (0.685 \\ \\mathrm{mg/mL}) \\times (1.15 \\ \\mathrm{mL/min}) = 0.78775 \\ \\mathrm{mg/min}$\n\nNow, we can set up a system of two equations. Cimetidine blocks a fraction $f=0.80$ of the baseline tubular secretion, so the secretion rate in condition $2$ is $TS_{Cr,2} = (1-f) \\times TS_{Cr,1}$.\n\nEquation for Condition 1:\n$$\nE_{Cr,1} = (GFR \\times P_{Cr}) + TS_{Cr,1}\n$$\n\nEquation for Condition 2:\n$$\nE_{Cr,2} = (GFR \\times P_{Cr}) + TS_{Cr,2} = (GFR \\times P_{Cr}) + (1-f) \\times TS_{Cr,1}\n$$\n\nWe can solve this system for $GFR$. Subtracting the second equation from the first:\n$$\nE_{Cr,1} - E_{Cr,2} = ((GFR \\times P_{Cr}) + TS_{Cr,1}) - ((GFR \\times P_{Cr}) + (1-f) \\times TS_{Cr,1})\n$$\n$$\nE_{Cr,1} - E_{Cr,2} = TS_{Cr,1} - (1-f) \\times TS_{Cr,1} = f \\times TS_{Cr,1}\n$$\nThis allows us to find the baseline tubular secretion rate:\n$$\nTS_{Cr,1} = \\frac{E_{Cr,1} - E_{Cr,2}}{f}\n$$\nSubstituting this expression for $TS_{Cr,1}$ back into the first equation:\n$$\nE_{Cr,1} = (GFR \\times P_{Cr}) + \\frac{E_{Cr,1} - E_{Cr,2}}{f}\n$$\nNow, we solve for $GFR$:\n$$\nGFR \\times P_{Cr} = E_{Cr,1} - \\frac{E_{Cr,1} - E_{Cr,2}}{f} = \\frac{f \\cdot E_{Cr,1} - (E_{Cr,1} - E_{Cr,2})}{f} = \\frac{(f-1)E_{Cr,1} + E_{Cr,2}}{f}\n$$\n$$\nGFR = \\frac{(f-1)E_{Cr,1} + E_{Cr,2}}{f \\cdot P_{Cr}}\n$$\nPlugging in the given and calculated values:\n- $f = 0.80$\n- $E_{Cr,1} = 0.864 \\ \\mathrm{mg/min}$\n- $E_{Cr,2} = 0.78775 \\ \\mathrm{mg/min}$\n- $P_{Cr} = 0.0048 \\ \\mathrm{mg/mL}$\n$$\nGFR = \\frac{(0.80-1)(0.864) + 0.78775}{0.80 \\times 0.0048} = \\frac{(-0.20)(0.864) + 0.78775}{0.00384}\n$$\n$$\nGFR = \\frac{-0.1728 + 0.78775}{0.00384} = \\frac{0.61495}{0.00384} \\approx 160.1432 \\ \\mathrm{mL/min}\n$$\nThis is the patient's absolute $GFR$. It must be normalized to the standard body surface area ($BSA$) of $1.73 \\ \\mathrm{m^2}$. The patient's $BSA$ is $1.84 \\ \\mathrm{m^2}$.\n$$\nGFR_{normalized} = GFR \\times \\frac{1.73 \\ \\mathrm{m^2}}{BSA_{patient}}\n$$\n$$\nGFR_{normalized} = (160.1432 \\ \\mathrm{mL/min}) \\times \\frac{1.73}{1.84} \\approx 150.571 \\ \\mathrm{mL/min \\ per \\ 1.73 \\ m^2}\n$$\nRounding to four significant figures gives $150.6 \\ \\mathrm{mL/min}$ per $1.73 \\ \\mathrm{m^2}$.\n\nRegarding the limitations of estimated glomerular filtration rate (eGFR) equations (e.g., MDRD, CKD-EPI) in pregnancy: these equations are regression models derived from data in large, non-pregnant populations relating plasma creatinine concentration ($P_{Cr}$) to $GFR$ measured by a gold-standard method. They are inaccurate in pregnancy for several critical reasons:\n1.  **Altered Physiology**: Pregnancy induces profound physiological changes not present in the populations used to derive the equations. The $GFR$ increases by up to $50\\%$ (physiologic hyperfiltration), while plasma volume expansion causes hemodilution. These factors systematically lower $P_{Cr}$ for any given true $GFR$, breaking the relationship assumed by the eGFR formulas.\n2.  **Lack of Validation**: The equations were not developed or validated in pregnant cohorts. When applied to pregnant women, they consistently and significantly underestimate the measured $GFR$.\n3.  **Variable Creatinine Production and Secretion**: Changes in muscle mass and potentially altered tubular handling of creatinine during gestation add further variability not accounted for by the static eGFR equations.\nFor these reasons, direct measurement of clearance (ideally with a filtration marker like inulin, or more practically with a timed urine collection for creatinine clearance) is necessary for accurate assessment of renal function in pregnancy. The method used in this problem, which further refines the creatinine clearance by accounting for secretion, represents a highly rigorous approach.\nThe final computed value is the best estimate for the patient's normalized GFR.\n\n$$\nGFR_{normalized} \\approx 150.6 \\ \\mathrm{mL/min/1.73 \\ m^2}\n$$", "answer": "$$\n\\boxed{150.6}\n$$", "id": "4470795"}, {"introduction": "The physiological changes in pregnancy have direct consequences for clinical diagnostics, altering the interpretation of common lab values. This practice [@problem_id:4470781] bridges the gap between renal physiology and clinical decision-making by first calculating the expected serum uric acid level based on pregnancy-induced changes in GFR and tubular handling. You will then use this calculated value within a Bayesian framework to determine the posterior probability of preeclampsia, illustrating how fundamental physiology underpins predictive medicine.", "problem": "A gravida at $34$ weeks of gestation exhibits physiologic and pathophysiologic changes in renal handling of uric acid. Assume the following are true and constant for this individual: the whole-body uric acid production rate is $R = 1.35$ mg/min; uric acid is freely filtered at the glomerulus; and at steady state, the serum uric acid concentration is determined by the balance between production and renal excretion. In early normal pregnancy, the glomerular filtration rate (GFR) is $180$ mL/min and the fractional excretion of uric acid (FEUA) is $0.25$. At $34$ weeks, due to developing hypertensive disease, the GFR is $120$ mL/min and FEUA is $0.15$.\n\nA clinical decision rule uses a serum uric acid threshold of $5.5$ mg/dL to classify the test as positive for predicting preeclampsia. The test parameters at this threshold are sensitivity $0.78$ and specificity $0.88$. The patient’s pre-test probability of preeclampsia based on clinical risk factors is $0.25$.\n\nUsing only first-principles definitions of renal clearance and probabilistic inference, and assuming steady state for uric acid, determine the patient’s posterior probability of preeclampsia at $34$ weeks given the above renal handling and the decision rule threshold. Express the final posterior probability as a decimal number. Round your final answer to four significant figures.", "solution": "The fundamental physiological base is the steady-state mass balance and the definition of renal clearance. At steady state, the rate of production of a solute equals its rate of excretion. For a solute that is freely filtered and subject to net tubular handling summarized by the fractional excretion, the renal clearance is the product of the glomerular filtration rate (GFR) and the fractional excretion. The key definitions are:\n\n- Renal clearance of uric acid, $C_{\\mathrm{UA}}$, is given by the product of glomerular filtration rate and fractional excretion of uric acid: \n$$\nC_{\\mathrm{UA}} = \\mathrm{GFR} \\times \\mathrm{FEUA}.\n$$\n\n- Steady-state balance for serum uric acid concentration, $P_{\\mathrm{UA}}$, given a constant production rate $R$ and clearance $C_{\\mathrm{UA}}$, satisfies:\n$$\nR = C_{\\mathrm{UA}} \\times P_{\\mathrm{UA}}.\n$$\nHence,\n$$\nP_{\\mathrm{UA}} = \\frac{R}{C_{\\mathrm{UA}}}.\n$$\n\nWe first compute the serum uric acid concentration at $34$ weeks using the provided renal parameters. The late pregnancy values are $\\mathrm{GFR} = 120$ mL/min and $\\mathrm{FEUA} = 0.15$. Therefore,\n$$\nC_{\\mathrm{UA,34w}} = 120 \\times 0.15 = 18 \\ \\text{mL/min}.\n$$\nWith $R = 1.35$ mg/min,\n$$\nP_{\\mathrm{UA,34w}} = \\frac{1.35}{18} = 0.075 \\ \\text{mg/mL}.\n$$\nTo express in mg/dL, note that $1$ dL $= 100$ mL, so:\n$$\nP_{\\mathrm{UA,34w}} = 0.075 \\times 100 = 7.5 \\ \\text{mg/dL}.\n$$\n\nThe decision rule classifies the test as positive if the serum uric acid is at least $5.5$ mg/dL. Since $7.5$ mg/dL $\\geq 5.5$ mg/dL, the test is positive.\n\nWe now compute the posterior probability of preeclampsia using probabilistic inference. The fundamental base is Bayes’ theorem, which can be conveniently expressed in odds form for diagnostic testing:\n\n- Define sensitivity $S$ and specificity $T$:\n$$\nS = 0.78, \\quad T = 0.88.\n$$\n- The positive likelihood ratio is:\n$$\n\\mathrm{LR}^{+} = \\frac{S}{1 - T} = \\frac{0.78}{1 - 0.88} = \\frac{0.78}{0.12} = 6.5.\n$$\n- Convert the pre-test probability $p_{0} = 0.25$ to pre-test odds:\n$$\no_{0} = \\frac{p_{0}}{1 - p_{0}} = \\frac{0.25}{0.75} = \\frac{1}{3} \\approx 0.333333\\ldots.\n$$\n- The posterior odds after a positive test are:\n$$\no_{1} = o_{0} \\times \\mathrm{LR}^{+} = \\frac{1}{3} \\times 6.5 = \\frac{6.5}{3} \\approx 2.166666\\ldots.\n$$\n- Convert posterior odds to posterior probability:\n$$\np_{1} = \\frac{o_{1}}{1 + o_{1}} = \\frac{2.166666\\ldots}{1 + 2.166666\\ldots} = \\frac{2.166666\\ldots}{3.166666\\ldots}.\n$$\nCompute the quotient:\n$$\np_{1} \\approx 0.6842105263\\ldots.\n$$\n\nRounded to four significant figures, the posterior probability is:\n$$\n0.6842.\n$$\n\nThis is the requested decimal posterior probability under the given renal handling and decision rule threshold.", "answer": "$$\\boxed{0.6842}$$", "id": "4470781"}, {"introduction": "Effective and safe pharmacotherapy in pregnancy demands an appreciation for altered drug disposition. This problem [@problem_id:4470787] models the real-world challenge of adjusting a diuretic dose, integrating pharmacokinetic principles with the known maternal adaptations of increased renal plasma flow and expanded volume of distribution. By balancing the need for therapeutic efficacy with the constraint of fetal safety, you will quantitatively determine an appropriate dose adjustment, highlighting the critical role of physiology in clinical pharmacology.", "problem": "A clinician is evaluating diuretic dosing in a pregnant patient, taking into account maternal renal and urinary tract adaptations to pregnancy. Consider a loop diuretic administered as a single intravenous bolus into a one-compartment system with first-order elimination. In the nonpregnant state, a $70 \\ \\mathrm{kg}$ woman exhibits adequate diuresis to a bolus dose of $40 \\ \\mathrm{mg}$, operationally defined as the amount of drug delivered to the tubular lumen within the first $1 \\ \\mathrm{h}$ matching the amount eliminated from plasma in that interval, given that renal clearance overwhelmingly dominates total clearance through active secretion in the proximal tubule. Assume the following:\n\n- In the nonpregnant state, renal plasma flow is $0.60 \\ \\mathrm{L} \\ \\mathrm{min}^{-1}$, the extraction ratio for renal secretion is constant at $0.80$, and nonrenal clearance is negligible. The apparent volume of distribution is $0.20 \\ \\mathrm{L} \\ \\mathrm{kg}^{-1}$.\n- In pregnancy at $28$ weeks, renal plasma flow increases by $50 \\%$ relative to the nonpregnant value, the extraction ratio for renal secretion remains $0.80$, nonrenal clearance remains negligible, and the apparent volume of distribution increases by $40 \\%$ relative to the nonpregnant value. The plasma unbound fraction increases from $0.02$ to $0.04$ in pregnancy due to reduced albumin concentration.\n- Placental transfer at peak maternal concentration is approximated by a proportionality factor $\\alpha = 0.80$ for unbound drug, so that the peak fetal unbound concentration equals $\\alpha$ times the peak maternal unbound concentration. A safety threshold requires that the peak fetal unbound concentration must not exceed $0.10 \\ \\mathrm{mg} \\ \\mathrm{L}^{-1}$.\n\nUsing only the information above and well-established pharmacokinetic and renal physiology principles, determine the minimal pregnancy bolus dose (in $\\mathrm{mg}$) that simultaneously (i) matches the nonpregnant first-hour delivery of drug to the tubular lumen and (ii) does not exceed the fetal unbound peak concentration threshold. Express your final answer in $\\mathrm{mg}$ and round to three significant figures.", "solution": "The problem statement has been critically validated and is deemed valid. It is scientifically grounded in established pharmacokinetic and physiological principles, is well-posed, and all necessary parameters for a unique solution are provided. The problem is self-contained and free of contradictions or ambiguities.\n\nThe task is to determine the minimal bolus dose of a loop diuretic in a pregnant patient, $D_P$, that satisfies two conditions:\n(i) The amount of drug eliminated in the first hour is equal to the amount eliminated in the first hour in a nonpregnant state with a $40 \\ \\mathrm{mg}$ dose.\n(ii) The peak fetal unbound concentration does not exceed a safety threshold of $0.10 \\ \\mathrm{mg} \\ \\mathrm{L}^{-1}$.\n\nThe solution involves a multi-step pharmacokinetic analysis. We assume a one-compartment model with first-order elimination following an intravenous bolus dose, $D$. The concentration of the drug in plasma at time $t$ is given by $C(t) = C(0) \\exp(-k_e t)$, where $C(0) = D/V_d$ is the initial concentration, $V_d$ is the apparent volume of distribution, and $k_e$ is the first-order elimination rate constant. The amount of drug eliminated from the body by time $t$ is $A_{\\text{elim}}(t) = D(1 - \\exp(-k_e t))$. The elimination rate constant $k_e$ is related to total body clearance $CL_T$ and volume of distribution by $k_e = CL_T / V_d$.\n\nFirst, we analyze the nonpregnant (NP) state to establish the target for condition (i).\nThe patient's mass is $m = 70 \\ \\mathrm{kg}$.\nThe nonpregnant volume of distribution is $V_{d,NP} = 0.20 \\ \\mathrm{L} \\ \\mathrm{kg}^{-1} \\times 70 \\ \\mathrm{kg} = 14 \\ \\mathrm{L}$.\nNonrenal clearance is negligible, so total clearance $CL_{T,NP}$ equals renal clearance $CL_{R,NP}$. Renal clearance is the product of renal plasma flow ($RPF_{NP}$) and the extraction ratio ($E_R$).\n$CL_{T,NP} = RPF_{NP} \\times E_R = (0.60 \\ \\mathrm{L} \\ \\mathrm{min}^{-1}) \\times 0.80 = 0.48 \\ \\mathrm{L} \\ \\mathrm{min}^{-1}$.\nThe nonpregnant elimination rate constant is:\n$$k_{e,NP} = \\frac{CL_{T,NP}}{V_{d,NP}} = \\frac{0.48 \\ \\mathrm{L} \\ \\mathrm{min}^{-1}}{14 \\ \\mathrm{L}} = \\frac{0.48}{14} \\ \\mathrm{min}^{-1}$$\nThe target amount of drug eliminated in the first hour ($t = 60 \\ \\mathrm{min}$) for a nonpregnant dose of $D_{NP} = 40 \\ \\mathrm{mg}$ is:\n$$A_{target} = A_{elim,NP}(t=60 \\ \\mathrm{min}) = D_{NP} \\left(1 - \\exp(-k_{e,NP} \\times 60 \\ \\mathrm{min})\\right)$$\n$$A_{target} = 40 \\ \\mathrm{mg} \\left(1 - \\exp\\left(-\\frac{0.48}{14} \\times 60\\right)\\right)$$\n\nNext, we analyze the pregnant (P) state.\nThe renal plasma flow increases by $50\\%$: $RPF_P = 1.50 \\times RPF_{NP} = 1.50 \\times 0.60 \\ \\mathrm{L} \\ \\mathrm{min}^{-1} = 0.90 \\ \\mathrm{L} \\ \\mathrm{min}^{-1}$.\nThe total clearance in pregnancy is:\n$CL_{T,P} = RPF_P \\times E_R = (0.90 \\ \\mathrm{L} \\ \\mathrm{min}^{-1}) \\times 0.80 = 0.72 \\ \\mathrm{L} \\ \\mathrm{min}^{-1}$.\nThe volume of distribution increases by $40\\%$: $V_{d,P} = 1.40 \\times V_{d,NP} = 1.40 \\times 14 \\ \\mathrm{L} = 19.6 \\ \\mathrm{L}$.\nThe elimination rate constant in pregnancy is:\n$$k_{e,P} = \\frac{CL_{T,P}}{V_{d,P}} = \\frac{0.72 \\ \\mathrm{L} \\ \\mathrm{min}^{-1}}{19.6 \\ \\mathrm{L}} = \\frac{0.72}{19.6} \\ \\mathrm{min}^{-1}$$\n\nNow, we determine the dose $D_{P,(i)}$ that satisfies condition (i). This dose must result in an amount eliminated in the first hour equal to $A_{target}$.\n$$A_{elim,P}(t=60 \\ \\mathrm{min}) = D_{P,(i)} \\left(1 - \\exp(-k_{e,P} \\times 60 \\ \\mathrm{min})\\right) = A_{target}$$\nSolving for $D_{P,(i)}$:\n$$D_{P,(i)} = \\frac{A_{target}}{1 - \\exp(-k_{e,P} \\times 60 \\ \\mathrm{min})} = \\frac{40 \\ \\mathrm{mg} \\left(1 - \\exp\\left(-\\frac{0.48}{14} \\times 60\\right)\\right)}{1 - \\exp\\left(-\\frac{0.72}{19.6} \\times 60\\right)}$$\nNumerically:\nThe exponent term for the nonpregnant state is $-k_{e,NP} \\times 60 = -2.05714...$.\nThe exponent term for the pregnant state is $-k_{e,P} \\times 60 = -2.20408...$.\n$$D_{P,(i)} = \\frac{40 \\ \\mathrm{mg} \\left(1 - \\exp(-2.05714...)\\right)}{1 - \\exp(-2.20408...)} = \\frac{40 \\ \\mathrm{mg} \\times (1 - 0.12781...)}{1 - 0.11035...} = \\frac{34.887... \\ \\mathrm{mg}}{0.88964...} \\approx 39.215 \\ \\mathrm{mg}$$\n\nNext, we determine the maximum permissible dose $D_{P,(ii)}$ according to condition (ii), the safety threshold.\nThe peak fetal unbound concentration $C_{u,fetal,peak}$ must not exceed $0.10 \\ \\mathrm{mg} \\ \\mathrm{L}^{-1}$.\n$C_{u,fetal,peak} = \\alpha \\times C_{u,maternal,peak} \\le 0.10 \\ \\mathrm{mg} \\ \\mathrm{L}^{-1}$, where $\\alpha = 0.80$.\nThis implies a maximum peak maternal unbound concentration of:\n$C_{u,maternal,peak,max} = \\frac{0.10 \\ \\mathrm{mg} \\ \\mathrm{L}^{-1}}{0.80} = 0.125 \\ \\mathrm{mg} \\ \\mathrm{L}^{-1}$.\nThe peak maternal concentration for an IV bolus is at $t=0$, $C_{maternal,peak} = D_P / V_{d,P}$.\nThe peak unbound concentration is $C_{u,maternal,peak} = f_{u,P} \\times C_{maternal,peak}$, where $f_{u,P} = 0.04$.\nSo, the maximum safe dose $D_{P,(ii)}$ is found by setting the peak unbound concentration to its maximum allowed value:\n$$f_{u,P} \\times \\frac{D_{P,(ii)}}{V_{d,P}} = C_{u,maternal,peak,max}$$\n$$D_{P,(ii)} = \\frac{C_{u,maternal,peak,max} \\times V_{d,P}}{f_{u,P}} = \\frac{0.125 \\ \\mathrm{mg} \\ \\mathrm{L}^{-1} \\times 19.6 \\ \\mathrm{L}}{0.04} = 61.25 \\ \\mathrm{mg}$$\n\nFinally, we must find the minimal dose that satisfies both conditions. The dose required to `match` the efficacy target is $D_{P,(i)} \\approx 39.215 \\ \\mathrm{mg}$. Any lower dose would not meet this target. We must verify if this dose is safe. The maximum safe dose is $D_{P,(ii)} = 61.25 \\ \\mathrm{mg}$.\nSince $D_{P,(i)}  D_{P,(ii)}$ ($39.215 \\ \\mathrm{mg}  61.25 \\ \\mathrm{mg}$), the dose required for efficacy is below the safety threshold. Therefore, the minimal dose that simultaneously matches the efficacy target and respects the safety constraint is $D_{P,(i)}$.\nRounding the result to three significant figures, we get $39.2 \\ \\mathrm{mg}$.", "answer": "$$\n\\boxed{39.2}\n$$", "id": "4470787"}]}